Sort
38,696 grants matching “als”
Pathogenic Mechanisms of Dynactin p150glued in ALS and Parkinson's Disease
$297,319Huaibin Cai · National Institute On Aging · ZIA · FY2012 · AG
CELL GENETIC DAMAGE AT LOW DOSE AND LOW DOSE RATES
$297,304Colorado State University-Fort Collins · R01 · FY2000 · CA
Disease Modeling Using Patient iPS Cell-Derived Cells and Organoids
$297,261Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
COVID-19 Instrumentation in the RTB
$297,252James Cherry · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Cerebral microhemorrhages and gait dysfunction in aging
$297,250Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · AG
Cerebral microhemorrhages and gait dysfunction in aging
$297,250Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2019 · AG
Cerebral microhemorrhages and gait dysfunction in aging
$297,250Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · AG
Cerebral microhemorrhages and gait dysfunction in aging
$297,250Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · AG
Cerebral microhemorrhages and gait dysfunction in aging
$297,250Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2018 · AG
Localized and distributed real-time fMRI approaches to facilitate self control in
$297,247Pearl H Chiu · Baylor College Of Medicine · R21 · FY2008 · DA
Parent Training and Emotion Coaching for Children with Limited Prosocial Emotions
$297,232Lynn Fainsilber Katz · University Of Washington · R34 · FY2015 · MH
Differential Response to the Dpp Morphogen
$297,165Christine A Rushlow · New York University · R01 · FY2010 · GM
A kinase pathway required for cortical neuron polarization
$297,160Franck Polleux · Univ Of North Carolina Chapel Hill · R01 · FY2009 · AG
A kinase pathway required for cortical neuron polarization
$297,160Franck Polleux · Univ Of North Carolina Chapel Hill · R01 · FY2008 · AG
Studying the role of KSHV-encoded microRNAs
$297,147Rolf F Renne · University Of Florida · R01 · FY2010 · CA
WITH REDUCED AVAILABILITY OF GRAZING LAND, ANNUAL AND INTER-ANNUAL VARIABLE PRECIPITATION, AND HIGH PRODUCTION COSTS, COW HERD PRODUCTION EFFICIENCY HAS TO INCREASE TO MEET THE PROJECTED INCREASE IN BEEF CONSUMPTION. IN DOING SO, COW-CALF PRODUCERS HAVE FOCUSED SELECTION EFFORTS ON INCREASED MILK PRODUCTION AND GREATER CALF GAINS TO IMPROVE OUTPUT-RELATED GROWTH TRAITS. HOWEVER, DURING THAT SAME TIME PERIOD, LALMAN ET AL. (2019) INDICATED CALF WEANING BODY WEIGHTS MAY HAVE BECOME STAGNANT IN SOME REGIONS OF THE UNITED STATES. THIS MAY INDICATE ENVIRONMENTAL CONSTRAINTS ON GROWTH TRAITS THROUGH MATERNAL GENETICS WITHIN FORAGE-BASED PRODUCTION SYSTEMS. IN ADDITION, THE CONTINUAL INCREASE IN SELECTION FOR MILK PRODUCTION HAS RESULTED IN BEEF COWS THAT ARE UNDER GREATER NUTRITIONAL STRESS IN CRITICAL PHYSIOLOGICAL PERIODS, SUCH AS EARLY LACTATION, THAT WILL ULTIMATELY REDUCE REPRODUCTIVE AND PRODUCTION EFFICIENCY. IN SELECTING FOR GROWTH WITH MATERNAL MILK, EDWARDS ET AL. (2017) REPORTED NO DIFFERENCE IN CALF WEANING WEIGHT, BUT A DECREASED IN REPRODUCTIVE PERFORMANCE IN HIGH-MILKING BEEF COWS. AS MILK PRODUCTION POTENTIAL INCREASES IN BEEF COWS, COW MAINTENANCE REQUIREMENTS DURING GESTATION AND LACTATION INCREASE. FOR INSTANCE, ENERGY REQUIREMENTS FOR COWS WITH A HIGH MILK PRODUCTION REQUIRED 11% MORE ENERGY TO SUPPORT AN INCREASED LEVEL OF MILK PRODUCTION COMPARED TO LOW MILK COWS. MATCHING COW TYPE OR GENETIC POTENTIAL TO THE PRODUCTION ENVIRONMENT IS AND WILL BE MORE IMPORTANT AS COST OF PRODUCTION INCREASES. PROJECTED ENVIRONMENTAL CHALLENGES AND INCREASED GLOBAL DEMAND FOR BEEF IN UPCOMING DECADES UNDERSCORE THE NEED TO UNDERSTAND THE BASIS FOR, AND IMPORTANCE OF INCREASE PRODUCTION EFFICIENCY IN BEEF COWS. FAILURE TO DO SO WILL IMPEDE EFFORTS TO OPTIMIZE EFFICIENCY UNDER LIMITING RESOURCES. IN THIS PROJECT, WE WILL DETERMINE THE IMPACT OF DAM MILK PRODUCTION LEVEL ON COW-CALF PERFORMANCE, GRAZING BEHAVIOR, AND PROFITABILITY. OUR GOAL IS TO INCREASE PRODUCTION EFFICIENCY IN GRAZING LACTATING BEEF COWS BY SELECTING FOR THE OPTIMAL COW TYPE (I.E., MILK POTENTIAL). THE OVERALL OBJECTIVE IN THIS APPLICATION IS TO DETERMINE THE IMPACT OF MILK PRODUCTION LEVEL ON COW PERFORMANCE, PROGENY PRE- AND POST-WEANING GROWTH. THE RATIONALE FOR THIS PROJECT IS THAT BALANCING THE ENVIRONMENT (FORAGE QUALITY AND QUANTITY) AND COW REQUIREMENTS IS THE FOUNDATION FOR PRODUCTION EFFICIENCY AND WILL IMPROVE THE PRODUCTION EFFICIENCY, PROFITABILITY, AND COMPETITIVENESS OF THE U.S. BEEF INDUSTRY.
$297,141Board Of Regents Of The University Of Nebraska · · FY2020 · National Institute of Food and Agriculture
Morphology Support
$297,047David S Milstone · Brigham And Women'S Hospital · P01 · FY2010 · HL
Determining the Structure, Function and Regulation of Dynein and Flagella
$297,045Daniela Nicastro · Brandeis University · R01 · FY2008 · GM
Mapping Transport Pathways through Nuclear Pores using 3D Super-Resolution Microscopy
$297,000Siegfried M Musser · Texas A&M University Health Science Ctr · R01 · FY2020 · GM
ITR: A Novel Framework with Fast Inverse Scattering Algorithms for Future Environmental Sensing
$297,000Qing Huo Liu · Duke University · · FY2002 · CSE
Novel functions for gp78 in ER-associated degradation
$297,000University Of Md Biotechnology Institute · R01 · FY2005 · GM
EQUITY IN ACCESS TO ALZHEIMER'S DISEASE PHARMACOLOGIC TREATMENT FOR AFRICAN AMERICAN AND WHITE PATIENTS IN ALABAMA A MIXED METHODS STUDY TO INFORM RECOMMENDATIONS EquAAL
$297,000Maria Pisu · University Of Alabama At Birmingham · R61 · FY2024 · AG
Novel functions for gp78 in ER-associated degradation
$297,000University Of Md Biotechnology Institute · R01 · FY2004 · GM
Mapping Transport Pathways through Nuclear Pores using 3D Super-Resolution Microscopy
$297,000Siegfried M Musser · Texas A&M University Health Science Ctr · R01 · FY2021 · GM
Mapping Transport Pathways through Nuclear Pores using 3D Super-Resolution Microscopy
$297,000Siegfried M Musser · Texas A&M University Health Science Ctr · R01 · FY2019 · GM